(Q34487826)

English

Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

0 references

1 reference

Europe PubMed Central

Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Alzheimer's disease

0 references

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Christopher Hyde

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jaime Peters

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Mary Bond

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Gabriel Rogers

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Rob Anderson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Mike Jeffreys

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sarah Davis

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Praveen Thokala

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Tiffany Moxham

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

22 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

14-20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179169%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Estimating the relationship between disease progression and cost of care in dementia

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Management of Patients with Alzheimer’s Disease plus Cerebrovascular Disease: 12-Month Treatment with Galantamine

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Cost-effectiveness of memantine for moderate to severe Alzheimer's disease in Sweden

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulation

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Economic evaluation of donepezil in moderate to severe Alzheimer disease

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: a 52-week prospective study

1 reference

https://api.crossref.org/works/10.1093%2FAGEING%2FAFS165

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34487826&oldid=1474441251"